E Merck introduces Livogen Z with zinc sulphate

by Medindia Content Team on  August 9, 2001 at 4:35 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

E Merck introduces Livogen Z with zinc sulphate
E Merck has launched Livogen Z, in the market with zinc sulphate.Livogen Z is one of the three versions of the trademark haematinic drug Livogen.Livogen was an old product of Glaxo India with Rs 3 crore revenue.Glaxo India Ltd has sold its Livogen brand to E Merck India Ltd.

According to a notification sent to the Bombay Stock Exchange (BSE), Glaxo India signed a memorandum of understanding with E Merck India, selling all the rights, title and interest in the registered trademark Livogen. This Mumbai based company, E Merck had purchased Livogen from Glaxo India Ltd for Rs 8 crore. The plain Livogen tablet as well as the Livogen Z tablet are available in the market.

E Merck had introduced the tonic version of Livogen Z even before the tablets. E Merck will have only one version of Livogen Z and it will contain zinc sulphate. Zinc decreases tubal defects in pregnant women.The launch of this drug was delayed, as E Merck had to take Karnataka Food and Drugs control Administration's permission to change the composition of the drug. E Merck is believed to have added zinc sulphate to Livogen Z as they felt it was unethical to sell otherwise.


Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Top Ten Selling Drugs Minerals: Not Just the Gold And Silver Foods High in Zinc 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive